MARK SHEPTOFF FINANCIAL PLANNING, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$510,000
+40.1%
4,800
-21.3%
0.35%
+49.4%
Q4 2017$364,000
+149.3%
6,1000.0%0.24%
+141.8%
Q3 2017$146,000
+121.2%
6,100
+79.4%
0.10%
+117.8%
Q2 2017$66,000
+247.4%
3,400
+324.5%
0.04%
+221.4%
Q1 2017$19,000
-50.0%
801
-74.2%
0.01%
-50.0%
Q4 2016$38,000
+5.6%
3,100
+47.6%
0.03%
+3.7%
Q3 2016$36,0002,1000.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2017
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders